Thomas Melillo, DPM
Foot & Ankle Surgery · Portland, ORNPI 1619085479
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,074 of the $3,274 with a category attached, or 63.4%. 25 manufacturers reported payments, led by Steelhead Surgical Inc at 38.7% of the total. Reporting peaked in 2021 at $1,389 and has fallen 70.9% since, to $404 in 2025.
Across 68 payments — averaging $48.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Steelhead Surgical Inc$1K
- Organogenesis Inc.$457
- Smith+Nephew$224
- Stryker$211
- Johnson & Johnson$192
- Treace Medical Concepts, Inc.$133
- plus $791 from 19 others
What the payments were for
- Food & beverage$2,07463%
- Education$1,20037%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Steelhead Surgical Inc | 3 | $1,267 |
| Organogenesis Inc. | 12 | $457 |
| Smith+Nephew | 10 | $224 |
| Stryker | 4 | $211 |
| Johnson & Johnson | 7 | $192 |
| Treace Medical Concepts, Inc. | 4 | $133 |
| Paragon 28, Inc. | 2 | $121 |
| Medtronic(2 entities) | 2 | $120 |
| Bioventus LLC | 5 | $100 |
| Left Coast Surgical Inc | 1 | $63 |
| Nevro Corp. | 2 | $53 |
| Fusion Orthopedics USA, LLC | 2 | $36 |
| Alafair Biosciences, Inc. | 1 | $33 |
| Heron Therapeutics, Inc. | 2 | $32 |
| Globus Medical | 1 | $28 |
| GRT US Holding, Inc. | 1 | $28 |
| Biocomposites Inc | 1 | $27 |
| KCI USA, Inc. | 1 | $26 |
| Averitas Pharma Inc. | 1 | $21 |
| Alfasigma USA, Inc. | 1 | $20 |
| Avita Medical Americas, LLC | 1 | $18 |
| Solventum Corporation | 1 | $18 |
| Kerecis Limited | 1 | $18 |
| Orthofix Medical, Inc. | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Apligraf$117
- Dermagraft$117
- Puraply/Affinity/NuTech$117
- PuraPly$114
- HawkOne$105
- PROPHECY$103
How this compares
$3,274 in reported general payments places this provider in the 55th percentile of 113 foot & ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciclopirox | 12 | $508 |
| Oxycodone Hcl | 22 | $146 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $132 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Portland
- Natalie MesnierPortland$339K
- Scott BoyntonPortland$120K
- Andrew ShinabargerPortland$85K
- Kevin DriscollPortland$21K
- John MassoudPortland$14K
- Kenneth HegewaldPortland$11K
- Steven LaxsonPortland$11K
- Lara AtwaterPortland$10K
- Denny lePortland$9K
- Andrew HuPortland$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.